A 1.85kb deletion extending into the Liprin-β gene from the P{EPgy2}Liprin-βEY22999 insertion site in the 5'UTR.
Approximate endpoints of deletion of reported length 1.85kb, which extends from P{EPgy2}Liprin-betaEY22999 into Liprin-beta.
14-17% of R7 axons show projections extending beyond the M6 layer of the medulla in Liprin-βΔ83/Liprin-βΔ51 mutants.
R7 axons show projections extending beyond the M6 layer of the medulla.
The number of synaptic boutons at the muscle 6/7 synapses in abdominal segments A2 and A3 in Liprin-βΔ51 animals is ~70% of that from control larvae.
Viability is 86% of the expected number.
Liprin-βΔ51 has partially lethal - majority die | recessive phenotype, enhanceable by Liprin-αoos
Liprin-βΔ51 has abnormal neuroanatomy phenotype, suppressible | partially by trioelav.Tag:MYC
Liprin-βΔ51 has abnormal neuroanatomy phenotype, non-suppressible by Liprin-γH1/Liprin-γS1
Liprin-βΔ51 is an enhancer of partially lethal - majority die | recessive phenotype of Liprin-αoos
Larunspecified, Liprin-βΔ51 has abnormal neuroanatomy phenotype
Liprin-αoos, Liprin-βΔ51 has abnormal neuroanatomy phenotype
Liprin-βΔ51 has NMJ bouton | larval stage phenotype, enhanceable by Liprin-αoos
Liprin-αoos, Liprin-βΔ51 has NMJ bouton | larval stage phenotype, suppressible | partially by Liprin-γH1/Liprin-γS1
Liprin-βΔ51 has photoreceptor cell R7 phenotype, suppressible | partially by trioelav.Tag:MYC
Liprin-βΔ51 has medulla phenotype, suppressible | partially by trioelav.Tag:MYC
Liprin-βΔ51 has NMJ bouton | larval stage phenotype, suppressible by Liprin-γH1/Liprin-γS1
Liprin-βΔ51 has photoreceptor cell R7 phenotype, non-suppressible by Liprin-γH1/Liprin-γS1
Liprin-βΔ51 has medulla phenotype, non-suppressible by Liprin-γH1/Liprin-γS1
Liprin-βΔ51 is an enhancer of NMJ bouton | larval stage phenotype of Liprin-αoos
Larunspecified, Liprin-βΔ51 has photoreceptor cell R7 phenotype
Larunspecified, Liprin-βΔ51 has medulla phenotype
Liprin-αoos, Liprin-βΔ51 has photoreceptor cell R7 phenotype
Liprin-αoos, Liprin-βΔ51 has medulla phenotype
In Liprin-αoos, Liprin-βΔ51 double mutants, many R7 axons terminate prematurely in the M3 layer of the medulla. However, a few R7 axons extend far beyond the boundary of the medulla.
In Larunspecified, Liprin-βΔ51 double mutants, many R7 axons terminate prematurely in the M3 layer of the medulla. However, a few R7 axons extend far beyond the boundary of the medulla.
Expression of trioelav.T:Hsap\MYC rescues the overgrowth of R7 axons in Liprin-βΔ51 mutants.
Liprin-αoos, Liprin-βΔ51 double mutants show an additional 25-30% decrease in bouton number compared with either single mutant. The viability of double mutants (4% of the expected number) is reduced compared to either single mutant.
Liprin-βΔ51, Liprin-γS1/Liprin-γH1 double mutants form more synaptic boutons than Liprin-βΔ51 single mutants and resemble controls.
Liprin-αoos, Liprin-βΔ51, Liprin-γS1/Liprin-γH1 triple mutant synapses are larger than Liprin-αoos, Liprin-βΔ51 double mutants.
Liprin-βΔ83/Liprin-βΔ51 is partially rescued by Scer\GAL4elav-C155/Liprin-βUAS.Tag:HA
Scer\GAL4elav-C155-mediated expression of Liprin-βScer\UAS.T:Ivir\HA1 significantly rescues the aberrant axon termination phenotype seen in Liprin-βΔ83/Liprin-βΔ51 mutants.
Scer\GAL4elav-C155-mediated expression of Liprin-βScer\UAS.T:Ivir\HA1 restores the number of boutons in Liprin-βΔ83/Liprin-βΔ51 animals to control levels.